What Researchers Did
Researchers in India tested a dressing pad for diabetic foot ulcers in a single-arm study and followed 49 patients for eight weeks.
What They Found
In a prospective, single-arm, multicenter study of 49 patients with diabetic foot ulcers, wound size and RESVECH 2.0 wound scores fell each week while using the Theruptor novo dressing pad, and 22 patients (45%) had complete healing before eight weeks. The abstract reports that the changes in wound size and RESVECH 2.0 scores were significant (p less than 0.05). The mean pain score went from 2.83 at Visit 2 to 0.72 at Visit 9 (p=0.0023). Satisfaction scores went from 2.75 to 4.45 over the same visits (p=0.013). Higher RESVECH 2.0 scores went with higher pain scores at Visit 2 only (r=0.392; p=0.02).
What This Means for Canadian Patients
This study tested a dressing pad, not hyperbaric oxygen therapy. The abstract mentions hyperbaric oxygen therapy only as one existing treatment for diabetic foot ulcers and does not address how it works or how it compares. Patients with a diabetic foot ulcer can use these results to understand how wounds and pain changed with this dressing in this group, and should talk with their care team about wound care options.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
All patients received the same dressing with no comparison group, so the abstract cannot show that the dressing caused the improvements, and the study ran at clinics in one Indian city for eight weeks.